Technology Licensing
Search documents
Pixelworks to Announce Fourth Quarter and Fiscal 2025 Financial Results on March 12, 2026
Prnewswire· 2026-01-29 21:05
PORTLAND, Ore., Jan. 29, 2026 /PRNewswire/ -- Pixelworks, Inc. (NASDAQ: PXLW), a provider of innovative cinematic and enhanced visualization solutions, will release its fourth quarter and fiscal 2025 financial results on Thursday, March 12, 2026, after market close. Todd DeBonis, Chairman, President and CEO, and Haley Aman, CFO, will host a conference call at 2:00 p.m. Pacific Time to discuss the Company's financial results. Analysts and investors are invited to join the Company's conference call using the ...
AiRWA Inc. Announces $15.69 Million Common Stock Registered Direct Priced At Market Close
Globenewswire· 2025-12-19 13:00
Core Viewpoint - AiRWA Inc. has announced a registered direct offering of 15,382,378 shares of common stock at a price of $1.02 per share, aiming to raise approximately $15.69 million in gross proceeds before expenses [1][2]. Group 1: Offering Details - The offering is expected to close around December 22, 2025, pending customary closing conditions [1]. - A.G.P./Alliance Global Partners is acting as the sole placement agent for this offering [2]. Group 2: Use of Proceeds - The net proceeds from the offering will be used for a previously announced joint venture, corporate acquisitions, and general working capital purposes, although no specific acquisition plans are currently in place [2]. Group 3: Company Background - AiRWA Inc. operates through its majority-owned subsidiary, Yuanyu Enterprise Management Co., Limited, and focuses on technology licensing, particularly in the area of tokenized U.S. equities [5]. - The company is also involved in the Web3 space, promoting innovation in digital finance through the AiRWA Exchange, which emphasizes the tokenization of real-world assets [5].
NewGen Reports Nine-Month 2025 Results with Balance Sheet Strengthened to $66.75 Net Asset Value Per Share
Globenewswire· 2025-12-02 13:00
Core Insights - NewGenIvf Group Limited reported a net income of $17.5 million for the nine months ended September 30, 2025, a significant turnaround from a net loss of $416,400 in the same period of 2024, primarily due to strategic acquisitions and a bargain purchase gain [3][4][10]. Financial Highlights - Total revenues for the nine months ended September 30, 2025, were $3.3 million, down from $4.2 million in the same period of 2024 [10]. - Cost of revenues remained stable at $2.9 million compared to the previous year [10]. - Total other income was $23.20 million, a substantial increase from a loss of $346,748 in the prior year, mainly due to a non-cash bargain purchase gain of $23.44 million from acquisitions [10]. - Basic earnings per share improved to $96.76 from a loss of $205.97 in the same period of 2024 [4][17]. Business Highlights - The company executed a strategic pivot towards acquiring high-value intellectual property, including the acquisition of MicroSort® technology and advanced cytometry IP from Nodexus, resulting in significant bargain purchase gains [3][4][10]. - NewGen is expanding into digital assets, planning to invest up to $30 million in Solana (SOL) and engaging in tokenization of a $2 million private art collection and a $100 million tranche of gold-backed assets [4][5]. - A joint venture in UAE real estate was established, securing a 60% ownership interest in a strategic land development project [4][5]. - The company is exploring a potential reverse merger with SAXA, Inc., which would provide access to mining assets [4][5]. Strategic Initiatives - The company has authorized a share repurchase program of up to $2 million over 24 months, reflecting management's confidence in the company's intrinsic value [4][5]. - A one-for-five reverse stock split was executed on December 1, 2025, to enhance the trading value of its shares [4][5].